Corporate Banner
Satellite Banner
Technology
Networks
Scientific Communities
 
Become a Member | Sign in
Home>Events>This Event
  Events - October 2012


Models of experimental pain: opportunities and challenges

11 Oct 2012 - 11 Oct 2012 - London, UK



Bookmark and Share


The NC3Rs, the British Pharmacological Society and the Physiological Society are hosting a joint symposium in central London on 11 October 2012 to discuss opportunities for developing new and better models of experimental pain, with reduced reliance on animal models.

Programme
The meeting will be chaired by Professor Stephen McMahon, King's College London, and confirmed speakers include:

    Professor Andrew Rice, Imperial College London
    Neuropathic pain: Refinement and enhancing the clinical relevance of rodent in vivo models
    Dr Nick Andrews, Harvard Medical School
    From reflex to voluntary assays: can we improved clinical translation of analgesics?
    Dr David Borsook, Harvard Medical School
    Imaging across analgesic drug development: A missing link?
    Professor Paul Flecknell, Newcastle University
    Pain or nociception what do our animals model?
    Dr Emily Sena, University of Edinburgh
    Systematic review and meta-analysis to improve animal models of pain.
    Dr Nathalie Percie du Sert, NC3Rs
    The ARRIVE guidelines
    Dr Lynne Sneddon, University of Liverpool
    Exploring the use of fish as models of nociception
    Dr Sean Sweeney, University of York
    Using Drosophila nociceptive responses to model sensory neuropathy
    Dr Kathryn Chapman, NC3Rs
    Using CRACK IT to generate new models of experimental pain
    Dr Mohammed Nassar, University of Sheffield
    Derivation of conditionally immortalised mouse DRG cell lines
    Dr James Bisland, Pfizer Neusentis
    Functional characterisation of human pluripotent stem cell derived sensory neurones



Further information
Scientific News
Breakthrough Flu Vaccine Inhibited by Pre-existing Antibodies
Universal truths – how existing antibodies are sabotaging the most promising new human flu vaccines.
Gene Therapy for Metabolic Liver Diseases
Researchers have tested gene therapy in pigs from hereditary tyrosinemia type 1, with corrected liver cells being transplanted into the diseased liver.
Zika Vaccine Candidates Show Promise
Two experimental vaccines have shown promise against a major viral strain responsible for the Brazilian Zika outbreak.
New Medication Shows Promise Against Liver Fibrosis in Animal Studies
Liver fibrosis is a gradual scarring of the liver that puts people at risk for progressive liver disease and liver failure.
Raw Eggs Deemed Safe to Eat
A report published today by the Advisory Committee on the Microbiological Safety of Food (ACMSF) into egg safety has shown a major reduction in the risk from salmonella in UK eggs.
Monitoring TTX Toxin in Shellfish
In a number of small studies, mussels and oysters from the eastern and northern part of the Oosterschelde in Holland were found to contain tetrodotoxin (TTX).
Gene Terapy for Muscle Wasting Developed
New gene therapy could save millions of people suffering from muscle wasting disease.
NIH Begins Yellow Fever Vaccine Trial
NIH has initiated an early-stage clinical trial of a vaccine to protect against yellow fever.
Gene-Editing 'Toolbox' Targets Multiple Genes Simultaneously
Researchers have designed a system that modifies, or edits, multiple genes in a genome at once while minimising unintentional effects.
Detecting Alzheimer's with Smell Test
Odour identification test may offer low-cost alternative for predicting cognitive decline and detecting early-stage Alzheimer’s disease.
Scroll Up
Scroll Down
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,300+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,900+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!